News summary

Science Corporation raises $400 million for its PRIMA retinal implant

Source: Longevity Docs News • Published: 20 Nov 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

A CE-marked implant restored some reading vision in geographic atrophy patients.

Science Corporation raises $400 million for its PRIMA retinal implant
Key Takeaways
  • PRIMAvera was single-arm and open-label only.
  • Eighty-one percent gained ≥0.2 logMAR at twelve months.
  • Safety events were concentrated in the early postoperative period.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.